Global Fund Replenishment: Success or Shortfall?

The fight against AIDS, tuberculosis and malaria faces a complex reality. Last week, The Global Fund to Fight AIDS, Tuberculosis and Malaria announced its Eighth Replenishment had “welcomed the final outcome” of US$12.64 billion. While many within the global health community are framing this as a success, a closer appear reveals a significant gap between ambition and result. The Fund itself had set a target of US$18 billion, a figure leadership clearly believed attainable, and one that underpinned projections of substantial impact.

The investment case supporting this higher target, published in The Lancet in July 2025, led by Tim Hallett and colleagues, estimated that deploying $18 billion, alongside existing domestic funding and other external donations, could save 23 million lives and prevent 400 million new cases and infections between 2027 and 2029. This discrepancy between the raised amount and the original goal raises questions about the future trajectory of these critical health programs.

A Shifting Landscape for Global Health Financing

The Global Fund’s Eighth Replenishment Summit, held in Johannesburg, South Africa, on November 21, 2025, was intended to galvanize international commitment to ending these three diseases. As co-hosts, South Africa and the UK championed solidarity and sustainability. However, the final figure suggests a potential shift in the global approach to health financing, one that may prioritize cautious incrementalism over bold, transformative investment.

This isn’t simply about a dollar amount. The $18 billion target wasn’t arbitrary. It was based on modeling that accounted for the interconnectedness of health systems, the rising costs of treatment and prevention, and the require to address the social determinants of health that fuel these epidemics. Falling short of that target could have cascading effects, slowing progress and potentially reversing gains made over the past two decades.

Beyond the Numbers: Understanding the Modeling

The Hallett-led study in The Lancet provides a crucial window into the assumptions underpinning the Global Fund’s ambitious goals. The research utilized complex modeling to estimate the impact of different investment scenarios. It’s important to understand that these models are not crystal balls. They rely on a range of assumptions about factors like treatment adherence, drug resistance, and the effectiveness of prevention programs.

the study, as with all modeling exercises, has limitations. It’s tricky to account for unforeseen events – like geopolitical instability, economic shocks, or the emergence of new variants – that could disrupt program implementation. The model also focuses primarily on the direct health impacts of the Global Fund’s investments, potentially underestimating the broader economic and social benefits of a healthier population.

The Malawi Case Study and Oxygen Access

Efforts to refine these models and improve their predictive power are ongoing. According to a planning update from the Global Fund Advocates Network, Tim Hallett (Imperial College London) is developing a case study for Malawi using the Thanzi La Onse model. This model aims to provide a more granular understanding of the impact of Global Fund investments at the country level.

Concurrently, Tim Colbourn (University College London) is working to estimate the impact of Global Fund investments on oxygen access, utilizing the Thanzi La Onse model. This is particularly relevant given the increased demand for oxygen during respiratory illnesses and the critical role it plays in treating severe cases of both tuberculosis and COVID-19 (though the latter is less prominent in current modeling).

What Does This Mean for Affected Populations?

The implications of this funding shortfall are most acutely felt by the populations most vulnerable to these diseases. Sub-Saharan Africa remains the epicenter of the AIDS, TB, and malaria epidemics, bearing the brunt of the global burden. Within these regions, marginalized communities – including women, children, and people living in poverty – are disproportionately affected. Reduced funding could lead to stockouts of essential medicines, weakened health systems, and a slowdown in the rollout of new prevention strategies.

For example, in malaria-endemic countries, a lack of funding could hinder efforts to distribute insecticide-treated bed nets, a proven intervention for preventing infection. In TB programs, it could limit access to diagnostic testing and multi-drug resistant TB treatment. And in HIV programs, it could slow progress towards achieving universal access to antiretroviral therapy.

The Role of Domestic Financing and Innovation

The Global Fund rightly emphasizes the importance of domestic financing in sustaining progress. However, many low- and middle-income countries are facing significant economic challenges, limiting their ability to increase health spending. This makes external assistance – like that provided by the Global Fund – even more critical.

Innovation also plays a vital role. New tools and strategies – like long-acting injectable antiretroviral therapy for HIV, more effective malaria vaccines, and shorter treatment regimens for TB – offer the potential to accelerate progress. But these innovations require significant investment to develop, deploy, and scale up.

Looking Ahead: Surveillance, Reviews, and Adaptive Strategies

The coming months will be crucial for assessing the impact of the Eighth Replenishment outcome. The Global Fund will need to carefully monitor program implementation, track key indicators, and adapt its strategies as needed. Ongoing surveillance of disease trends, drug resistance patterns, and health system capacity will be essential.

Regular reviews of the investment case, incorporating new data and insights, will also be critical. This includes revisiting the assumptions underlying the modeling and refining the projections of impact. The Global Fund must also work closely with national governments and civil society organizations to ensure that resources are allocated effectively and that programs are reaching those most in need. The conversation now shifts to how to maximize the impact of the available resources and to advocate for increased funding in future replenishment cycles.